-
As part of a longitudinal study of host/parasite relationships, which was initiated in two Senegalese villages in 1990 (and initially focused on malaria and tick-borne borreliosis), the potential of T. whipplei to cause infection in patients with fever of unknown etiology and negative test results for malaria was initiated in late 2008 and continued until the summer of 2009.
-
In this issue: Antiviral drugs and birth defects, bisphosphonates and esophageal cancer, naltrexone plus bupropion for weight loss, 2010-11 influenza vaccine, FDA Actions.
-
A retrospective review of CDC laboratory records identified five cases of tick-borne encephalitis (TBE) among U.S. travelers between 2000 and 2009.
-
The advisory committee on immunization practices (APIC) and the CDC have updated for the use of the 23 valent pneumococcal polysaccharide vaccine (PPSV23) for the prevention of invasive pneumococcal disease in adults.
-
With antimicrobial resistance among clinical bacterial isolates becoming a greater problem with each passing year, the need for novel antibacterial agents has become more urgent than ever.
-
In countries endemic for malaria, young children often receive empiric antimalarial therapy for febrile illness, resulting in over treatment and expense.
-
-
-
In the latest move in its dramatically expanding oversight of health care associated infection (HAI) programs, the Centers for Medicare and Medicaid Services (CMS) is calling for hospitals to report central line associated bloodstream infections (CLABSIs) to ensure full reimbursement for care. With several infection-control initiatives underway, CMS is lining
-
"I have climbed Mount Rainier five times. Each time I made that tough trek, my risk of dying was about 100 times smaller than the risk I will face on the operating table." Don Berwick, director of the Centers for Medicare and Medicaid Services (CMS)
